Andere talen Amgen Inc.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
262,7 ^USD	-0,53%		-2,71%	-8,80%

17/04	AMGEN INC. : UBS is Neutraal gestemd over aandeel	ZM
15/04	AMGEN INC. : TD Cowen herhaalt koopadvies	ZM

Amgen : First Cancer Diagnosis Led to a Dark Place—Aiding Another Helped Lift Him Out of It	17/04
AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024	17/04
Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease	16/04
Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker	16/04
Neumora's early-stage schizophrenia drug study put on hold	15/04
Amgen : CEO Bob Bradway's 2023 Letter to Shareholders	10/04
Amgen : Chairman and CEO Letter and Amgen Inc. 2023 Annual Report	10/04
Morgan Stanley Raises 2024, 2025 EPS Estimates for Regeneron Pharmaceuticals, Amgen	09/04
Boehringer to lay off salespeople as Humira biosimilar sales lag	05/04
Boehringer to lay off salespeople as Humira biosimilar sales lag	05/04
Amgen : How the LATTICE™ Consortium Is Igniting Action and Innovation in Cardiovascular Care	04/04
US takes next step in Medicare drug price negotiations with pharma companies	02/04
Amgen : Amazon, GameStop, Merck...les valeurs à suivre aujourd'hui à Wall Street	27/03
Amgen : s'allie à Gustave-Roussy sur les anticorps conjugués	27/03
Updates On Aflibercept BPCIA Litigation	26/03
Amgen : Jean-Charles Soria Elected to American Association for Cancer Research Board of Directors	19/03
FDA Approves Sandoz Denosumab Biosimilars	18/03
USPTO Releases Post-Amgen Guidance For Determining Enablement	15/03
USPTO Updates Guidance On Enablement	11/03
ETF der Woche: Auf die Wende der Biotechs setzen	10/03

Geen resultaten voor deze zoekopdracht